Drug Stocks Mixed Today (Cell Therapeutics, Amylin Pharmaceuticals, PharmAthene)
Cell Therapeutics, Inc. (NASDAQ:CTIC) surged 1.84% to $0.382. Cell Therapeutics, Inc. develops, acquires and commercializes treatments for cancer. It focuses on building a biopharmaceutical company with a diversified portfolio of oncology drugs. Its research, development, acquisition and in-licensing activities concentrate on identifying and developing less toxic ways to treat cancer. Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) slid [...]
Amylin Pharmaceuticals, Inc. (AMLN) Recovers From Recent Falls
Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) shares are bouncing back from its over 46% single day fall on Oct 19, 2010. The stock is now up 5.20% to $12.15 with over 2.50 million shares have traded hands. On Oct 19, 2010, the stock plunged after The maker of the diabetes treatment Byetta canceled a quarterly- update conference [...]